The Royal Belgian Society of Rheumatology takes great pleasure in announcing the 29th Belgian Congress of Rheumatology, taking place in Antwerpen on 24-26 September 2025.
This year’s congress will take place at Hilton Antwerp Old Town.
10.00
Young Investigators’ Meeting
10.00
Selected Abstract Presentations
12.00
Welcome Lunch
12.45
Opening Ceremony
11.00
SESSION 1: To the bone: The experts’ guide to osteoarthritis & osteitis
13.00
Bone and Joint Lecture
Osteoarthritis treatment innovation: Emerging strategies and future perspectives
Jérémie Sellam, Sorbonne University, Paris, France
13.35
What you should know on chronic nonbacterial osteitis
Liesbeth Winter, Leiden University Medical Center, Leiden, The Netherlands
14.10
Selected Abstract Presentations
Bone mineral density and bone micro-architecture modifications after kidney transplantation: Association with early changes in bone turnover biomarkers
Olivier Malaise (CHU de Liège)
14.20
Low-dose CT reveals syndesmophyte progression in axSpA, particularly in the thoracic spine: Insights from the SPACE cohort covering early and established disease
Manouk de Hooge (UZ Gent)
14.30
METHOFRACT, a methotrexate osteopathy multicentric cohort study
François Robin (French Society of Rheumatology)
14.40
Coffee Break
11.00
SESSION 2: Not child’s play: Lessons from rare pediatric disorders
15.10
Novel/adaptive designs for rare diseases – Paediatric model
Athimalaipet Ramanan, Bristol Royal Hospital for Children & University of Bristol, Bristol, UK
15.40
Fundamental immunology shapes the diagnosis and treatment of patients with rare immune disorders
Selket Delafontaine (KUL)
Selected Abstract Presentations
16.10
Apolipoprotein A1 and B levels indicate specific lipid changes in early treatment naïve psoriatic arthritis and correlate with 1-year disease activity
Alla Ishchenko (KUL)
16.20
Ultrasound detection of monosodium urate crystal joint deposition and related comorbidities in patients with asymptomatic hyperuricemia
Alina Stiuliuc (CHU Brugmann)
16.30
The spectrum of renal tubular acidosis in primary Sjögren’s disease: A BeSSTT cohort study
Sophie Vanhoof (VIB-Ugent)
16.40
Pneumocystis jirovecii pneumonia in patients with systemic inflammatory diseases: Risk profile and prophylaxis considerations
Cédric Peters (CHU de Liège)
16.50
Coffee Break
11.00
SESSION 3: Ethics and Economy
17.20
Update from BRV-AMRB
Philip Remans, President BRV-AMRB
17.40
Structured health data: The road to Mordor
Mark Helbert (ZAS)
18.40
From insight to impact: What Rheuma.be membership can do for you!
Laurent Méric de Bellefon, President KBVR-SRBR
Saskia Verwijs, Managing Director KBVR-SRBR
19.00
Update from ReumaNet/CLAIR and BeHPR
Veerle De Pourcq (ReumaNet)
Véronique Frennet (CLAIR)
Thanny Bries (BeHPR)
19.20
Welcome Reception
20.15
End of Day 1
11.00
SESSION 4: Reality bytes: Pragmatic wisdom for the management of rheumatoid arthritis
09.00
Update in Therapeutics – Organised with an educational grant from Alfasigma
Unraveling RA pathogenesis: Translation into clinical practice and real-world impact
Ernest Choy, Cardiff University, Cardiff, UK
09.30
Update in Therapeutics – Organised with an educational grant from AbbVie
Lessons from the RABBIT registry
Anja Strangfeld, Charité – Universitätsmedizin Berlin, Germany
10.00
Art’s debt to musculoskeletal knowledge
Alain Saraux, Centre hospitalier universitaire de Brest, Brest, France
10.20
Abstract presentations
Does first-line biologic choice influence progression to difficult-to-treat rhumatoid arthritis? Insights from our longitudinal RA UCLouvain Brussels cohort
Cécile Van Mullem (UCL)
10.30
Validation of novel autoantibody biomarkers for first-line therapy in rheumatoid arthritis in the Cap48 cohort
Sukayna Fadlallah (UHasselt)
10.40
Predicting pain outcomes in treatment-naïve early rheumatoid arthritis patients: Insights from a 5-year longitudinal RA UCLouvain Brussels cohort
Patrick Durez (UCL)
10.50
Coffee Break
11.00
SESSION 5: And in local news….
11.20
11.45
René Westhovens (KUL)
Year in review
Olivier Malaise (CHU de Liège)
FWRO Award Ceremony
13.30
to
14.15
Parallel training sessions (13.30 – 14.15):
Hands-on training e-platform Clinical patient management system
Yves Piette (UGent, AZ Sint-Jan Brugge – Oostende)
EULAR/SCTC consensus on standardised interpretation and description of nailfold videocapillaroscopy
Vanessa Smith (UGent)
12.10
My PhD project in five minutes
12.40
General Assembly
13.15
Lunch Break
14.00
Poster Viewing
11.00
SESSION 6: Quench the spark? Damage-control in systemic autoimmunity
14.30
Treatment of fibrotic manifestations of SSc
Jörg Distler, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
15.00
Vesalius Lecture
Lessons from targeting B lineage cells in systemic autoimmunity: SLE as a model
Thomas Dörner, Charité – Universitätsmedizin Berlin, Germany
15.35
Abstract Presentations
Early prediction of long-term renal outcomes in lupus nephritis using hazard index equations
Farah Tamirou (UCL)
15.45
Synergistic risk of systemic sclerosis from silica exposure and HLA-DQB1*03:01/03:04 genotype: A Belgian case-control study
Anne-Catherine Dens (UZ Leuven)
15.55
Role of a rare variant in the NT5E gene in the pathogenesis of systemic sclerosis
Gaëlle Tilman (UCL
16.05
Coffee break
11.00
SESSION 7: Both sides of the aisle: Fibromyalgia and polymyalgia rheumatica
16.35
Optimal care of patients diagnosed with fibromyalgia
Fabiola Atzeni, University of Messina, Messina, Italy
17.05
Update in Therapeutics – Organised with an educational grant from Novartis
The patient journey in polymyalgia rheumatica
Alain Saraux, Centre hospitalier universitaire de Brest, Brest, France
17.35
17:45
17:55
Thieves’ Market Best Clinical Case Contest – Young (future) Rheumatologists
The lymph node that solved the mystery: When Kikuchi-Fujimoto mimics encephalitis
Zoé Gendebien (CHU de Liège)
Sjogren’s syndrome with serious manifestations or just a B-cell lymphoma?
Iro Ioanna Giannakopoulou (CHU Saint-Pierre)
From gout to disseminated bone and cutaneous M. chelonae infection in a heart transplant recipient
Pauline Salpetier (CHU de Liège)
18.15
Voting & Thieves’ Market Award Presentation
18.30
19:30
Adjourn
Congress Dinner
11.00
WORKSHOPS
09.00 – 09.45
Workshop 1 – Organised with an educational grant from Abbvie
Prescribing targeted synthetic and biologic DMARDs
Anja Strangfeld, Charité – Universitätsmedizin Berlin, Germany
09.00 – 09.45
Workshop 2 – Organised with an educational grant from Alfasigma
The treatment of chronic pain in RA
Patrick Verschueren (KUL)
09.00 – 09.45
Workshop 3 – Organised with an educational grant from Lilly
Tools for rheumatologists for the assessment of skin and nails of patients with PsA
Dennis McGonagle, University of Leeds, Leeds, UK
09.00 – 09.45
Workshop 4 – Organised with an educational grant from Novartis
Connecting rheumatologists with their radiologists: Practical tips to get the best CT and MR imaging studies
Lennart Jans, UGent
09.45 – 10.00
Transfer time
10.00 – 10.45
Workshop 1 – Organised with an educational grant from Abbvie
Prescribing targeted synthetic and biologic DMARDs
Anja Strangfeld, Charité – Universitätsmedizin Berlin, Germany
10.00 – 10.45
Workshop 2 – Organised with an educational grant from Alfasigma
The treatment of chronic pain in RA
Patrick Verschueren (KUL)
10.00 – 10.45
Workshop 3 – Organised with an educational grant from Lilly
Tools for rheumatologists for the assessment of skin and nails of patients with PsA
Dennis McGonagle, University of Leeds, Leeds, UK
10.00 – 10.45
Workshop 4 – Organised with an educational grant from Novartis
Connecting rheumatologists with their radiologists: Practical tips to get the best CT and MR imaging studies
Lennart Jans, UGent
10.45
Coffee Break
11.00
SESSION 8: Know thy enemy: Pathogenic mechanisms in SpA and PsA
11:15
Update in Therapeutics – Organised with an educational grant from UCB
Progress in our understanding of pathological mechanisms, and the impact this may have on the treatment of spondylarthropathies
Frank Behrens, Goethe-University & Fraunhofer ITMP Frankfurt am Main, Germany
11:45
Update in Therapeutics – Organised with an educational grant from Lilly
From fingertips to joints: Understanding the link between nails and joints in psoriatic arthritis
Dennis McGonagle, University of Leeds, Leeds, UK
12:15
Update in Therapeutics – Organised with an educational grant from Amgen
Comorbidities in psoriatic disease: what is next?
Kurt de Vlam (KUL)
12:45
Update in Therapeutics – Organised with an educational grant from Janssen-Cilag
Joining forces in conquering PsA and IBD side by side
Marc Ferrante (KUL) & Gaëlle Varkas (UGent)
13.15
Closure of the Congress
13.30
Farewell Lunch
A number of hotel rooms have been booked at special group rates.
These rates only apply for reservations made through Medicongress.
You can reserve your hotel room through the online registration form.
Any requests for hotel accommodation must be accompanied by a valid credit card number, in order to secure the room. Participants will have to pay their room and personal expenses at the reception of the hotel.
In case of late cancellation or no show, the room will be charged on the credit card.
Hotel | Registration Fees | Cancellation Policy |
---|---|---|
Hotel IBIS Namur Centre*** | Single Room: € 105,00/night Double Room: € 121,00/night WiFi & Breakfast are included. City Tax: € 1,25/person/night | Free cancellation untill 1 month before the day of arrival. Late cancellation or no show: 100% will be charged. |
Registration Fees | EARLY (until 31 Aug) | LATE (as of 1 Sept) |
---|---|---|
Member KBVR-SRBR | € 300,00 | € 400,00 |
Non-Member | € 400,00 | € 500,00 |
Trainee in Rheumatology* | € 50,00 | € 75,00 |
Other Trainee* | € 75,00 | € 100,00 |
Research non-MD* | € 50,00 | € 75,00 |
Emeritus | € 50,00 | € 75,00 |
Congress Dinner | € 75,00 | € 75,00 |
Healthcare Professionals' Meeting on Thursday (19 Sept) | FREE | FREE |
* Registration as a trainee or researcher will only be accepted if accompanied by a copy of your student card or a certificate of your director (proof to be uploaded during the registration process). Without proof the non-member fee will be charged.
When your registration is completed successfully, you will receive an automatic confirmation. You can also print an invoice when you finalise your online registration.
All payments are to be made in EURO, net of all bank charges and commissionf for the receiver.
Payment is to be made by:
You will receive a personal link in your final confirmation email. With this link it will be possible to make changes or transfer your registration to a colleague free of charge.
Participants canceling their registration before 1 September 2024, will receive a full refund, less administration costs (€ 50 for members and non-members and € 25 for trainees, researchers and emeriti). There will be no refunds for cancellations received after this date. Cancellations must be confirmed in writing to the Organising Secretariat. All refunds will be processed after the Congress.
Belgian accreditation will be requested.
These terms and conditions apply to all payments/registrations made to Medicongress Services. By using the online payment facility on this website you implicitly accept these general terms and conditions.
By entering your credit card information:
You state that you are an authorized user of the credit card and that the associated information entered is accurate. You authorize Medicongress Services to charge the booked amount to your credit card.
Declined/ Refused payments:
We cannot accept liability if the payment is refused or declined by the credit/ debit card supplier (due to the customer quoting incorrect card details or other reasons).
In registering for the 28th Belgian Congress on Rheumatology, participants agree that neither BCR 2024 nor the Organizing Secretariat assume any liability whatsoever. Participants should therefore organize their own health, travel and personal insurances.
MediCongress is committed to protecting your personal data. The privacy notice on our website outlines how we collect, share and use your personal data, and how you can exercise your privacy rights involving your data.
Authors can submit their abstracts for oral or poster presentation. It is to be noted that the Scientific Committee will select a limited number of abstracts for oral presentation in the Young Investigators’ Meeting, the abstract sessions and the Thieves Market (send us your most remarkable clinical cases!). The other abstracts will be accepted for poster presentation, after peer review (see scoring and evaluation guidelines below).
The three most challenging clinical cases submitted for the Thieves Market will be selected by the scientific committee for an oral presentation. This year, a 500 € prize will be awarded to the young clinician who presents the best of these three selected clinical cases. Only trainees or rheumatologists within maximum 3 years of board certification can apply.
Encore abstracts are accepted.
Authors will be notified of the acceptance of their abstract by email by mid June 2025.
Download the abstract template here.
You can submit several abstracts at the same time and add abstracts later on:
Your abstract(s) is/are only uploaded successfully when you receive an automatic reply confirming your submission(s).
IMPORTANT: The uploaded Word file(s) must contain title, authors & affiliations and the actual abstract.
Click here for step by step guidance through the online submission procedure.